Efforts in Africa and elsewhere hit by decision not to export AstraZeneca jab from India until end of year
Vaccine programmes across Africa and much of the developing world will suffer big delays after the world’s biggest producer said it would not be exporting the Oxford/AstraZeneca vaccine until the end of the year.
The decision is likely to leave the Covax global vaccine-sharing facility, which helps poor countries, facing a shortfall of hundreds of millions of doses.
